The Latin America, Middle East and Africa Nasal Splints Market would witness market growth of 7.1% CAGR during the forecast period (2024-2031). In the year 2027, the LAMEA market's volume is expected to surge to 5,328.3 thousand units, showcasing a growth of 8.8% (2024-2031).
External nasal splints play a crucial role in the Market by providing external support and protection to the nose following surgeries or trauma. These splints are typically placed outside the nose and secured with adhesive or straps to provide stabilization and maintain the desired shape during the healing process. One primary use of external nose splints is in rhinoplasty procedures, where they help to support the newly sculpted nasal contours and minimize post-operative swelling and bruising. Therefore, the Brazil market consumed 599.38 thousand units of external splints in 2023.
The Brazil market dominated the LAMEA Nasal Splints Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $48.9 million by 2031. The Argentina market is showcasing a CAGR of 7.7% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 6.8% during (2024 - 2031).
The market has witnessed significant growth and evolution in recent years, driven by technological advancements, increasing prevalence of nasal conditions, rising demand for minimally invasive treatments, and growing awareness about the benefits of splint therapy. They serve various applications across various medical specialties, including otolaryngology, maxillofacial surgery, and rhinology, and are increasingly being adopted as essential tools in managing nasal conditions.
In addition, advancements in nasal splint design, materials, and fabrication techniques have led to the development of more effective and patient-friendly splinting solutions that offer improved comfort, stability, and clinical outcomes. Innovative features such as adjustable sizing, anatomical shaping, and customizable configurations have enhanced the versatility and applicability of nose splints across a wide spectrum of nasal conditions, patient demographics, and clinical settings.
Saudi Arabia is investing significantly in healthcare infrastructure, attracting medical tourists from neighboring countries. These tourists may undergo various medical procedures, including those involving nose splints. According to the International Trade Administration data, the Saudi Arabian government continues to prioritize healthcare, with Saudi Arabia accounting for 60% of the Gulf Cooperation Council (GCC) countries’ healthcare spending. It was projected to spend $50.4 billion on healthcare and social development in 2023, representing 16.96 percent of its budget and ranking second only to education in terms of expenditure. Thus, the rising healthcare services in LAMEA will drive the expansion of the regional market.
Based on Mechanism, the market is segmented into Intranasal, and External. Based on Application, the market is segmented into Septoplasty, and Rhinoplasty. Based on Type, the market is segmented into Malleable, Airway, and Bivalve. Based on End-user, the market is segmented into Outpatients, and Hospitals. Based on Material Type, the market is segmented into Silicon Splints, Plastic Splints, Metal Splints, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
External nasal splints play a crucial role in the Market by providing external support and protection to the nose following surgeries or trauma. These splints are typically placed outside the nose and secured with adhesive or straps to provide stabilization and maintain the desired shape during the healing process. One primary use of external nose splints is in rhinoplasty procedures, where they help to support the newly sculpted nasal contours and minimize post-operative swelling and bruising. Therefore, the Brazil market consumed 599.38 thousand units of external splints in 2023.
The Brazil market dominated the LAMEA Nasal Splints Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $48.9 million by 2031. The Argentina market is showcasing a CAGR of 7.7% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 6.8% during (2024 - 2031).
The market has witnessed significant growth and evolution in recent years, driven by technological advancements, increasing prevalence of nasal conditions, rising demand for minimally invasive treatments, and growing awareness about the benefits of splint therapy. They serve various applications across various medical specialties, including otolaryngology, maxillofacial surgery, and rhinology, and are increasingly being adopted as essential tools in managing nasal conditions.
In addition, advancements in nasal splint design, materials, and fabrication techniques have led to the development of more effective and patient-friendly splinting solutions that offer improved comfort, stability, and clinical outcomes. Innovative features such as adjustable sizing, anatomical shaping, and customizable configurations have enhanced the versatility and applicability of nose splints across a wide spectrum of nasal conditions, patient demographics, and clinical settings.
Saudi Arabia is investing significantly in healthcare infrastructure, attracting medical tourists from neighboring countries. These tourists may undergo various medical procedures, including those involving nose splints. According to the International Trade Administration data, the Saudi Arabian government continues to prioritize healthcare, with Saudi Arabia accounting for 60% of the Gulf Cooperation Council (GCC) countries’ healthcare spending. It was projected to spend $50.4 billion on healthcare and social development in 2023, representing 16.96 percent of its budget and ranking second only to education in terms of expenditure. Thus, the rising healthcare services in LAMEA will drive the expansion of the regional market.
Based on Mechanism, the market is segmented into Intranasal, and External. Based on Application, the market is segmented into Septoplasty, and Rhinoplasty. Based on Type, the market is segmented into Malleable, Airway, and Bivalve. Based on End-user, the market is segmented into Outpatients, and Hospitals. Based on Material Type, the market is segmented into Silicon Splints, Plastic Splints, Metal Splints, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Olympus Corporation
- Medtronic PLC
- Smith & Nephew PLC
- Surgiform Technology Ltd. (STL Group, Inc.)
- Teleflex Incorporated
- ENTPROMED Healthcare Products Inc.
- E.Benson Hood Laboratories, Inc.
- Audio Technologies SRL (Innovative-RFK Spa)
- Anthony Products Inc.
- Boston Medical Products, Inc. (Bess AG)
Market Report Segmentation
By Mechanism (Volume, Thousand Units, USD Billion, 2020-31)- Intranasal
- External
- Septoplasty
- Rhinoplasty
- Malleable
- Airway
- Bivalve
- Outpatients
- Hospitals
- Silicon Splints
- Plastic Splints
- Metal Splints
- Others
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. LAMEA Nasal Splints Market by Mechanism
Chapter 5. LAMEA Nasal Splints Market by Application
Chapter 6. LAMEA Nasal Splints Market by Type
Chapter 7. LAMEA Nasal Splints Market by End-user
Chapter 8. LAMEA Nasal Splints Market by Material Type
Chapter 9. LAMEA Nasal Splints Market by Country
Chapter 10. Company Profiles
Companies Mentioned
- Olympus Corporation
- Medtronic PLC
- Smith & Nephew PLC
- Surgiform Technology Ltd. (STL Group, Inc.)
- Teleflex Incorporated
- ENTPROMED Healthcare Products Inc.
- E. Benson Hood Laboratories, Inc.
- Audio Technologies SRL (Innovative-RFK Spa)
- Anthony Products Inc.
- Boston Medical Products, Inc. (Bess AG)
Methodology
LOADING...
